» Articles » PMID: 34575791

Cytokine and Chemokine Responses in Invasive Aspergillosis Following Hematopoietic Stem Cell Transplantation: Past Evidence for Future Therapy of Aspergillosis

Overview
Journal J Fungi (Basel)
Date 2021 Sep 28
PMID 34575791
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Invasive pulmonary aspergillosis is a frequent complication in immunocompromised individuals, and it continues to be an important cause of mortality in patients undergoing hematopoietic stem cell transplantation. In addition to antifungal therapy used for mycoses, immune-modulatory molecules such as cytokines and chemokines can modify the host immune response and exhibit a promising form of antimicrobial therapeutics to combat invasive fungal diseases. Cytokine and chemokine profiles may also be applied as biomarkers during fungal infections and clinical research has demonstrated different activation patterns of cytokines in invasive mycoses such as aspergillosis. In this review, we summarize different aspects of cytokines that have been described to date and provide possible future directions in research on invasive pulmonary aspergillosis following hematopoietic stem cell transplantation. These findings suggest that cytokines and chemokines may serve as useful biomarkers to improve diagnosis and monitoring of infection.

Citing Articles

Current status and new experimental diagnostic methods of invasive fungal infections after hematopoietic stem cell transplantation.

Tang Z, Wang H, Liu Y, Wang C, Li X, Yang Q Arch Microbiol. 2024; 206(5):237.

PMID: 38678508 DOI: 10.1007/s00203-024-03905-9.


Interplay of Cytokines and Chemokines in Aspergillosis.

Shankar J, Thakur R, Clemons K, Stevens D J Fungi (Basel). 2024; 10(4).

PMID: 38667922 PMC: 11051073. DOI: 10.3390/jof10040251.


Circulatory Inflammatory Proteins as Early Diagnostic Biomarkers for Invasive Aspergillosis in Patients with Hematologic Malignancies-an Exploratory Study.

Aerts R, Ricano-Ponce I, Bruno M, Mercier T, Rosati D, Maertens J Mycopathologia. 2024; 189(2):24.

PMID: 38407673 PMC: 10896822. DOI: 10.1007/s11046-024-00831-8.


Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis.

Sullivan B, Baggett M, Guillory C, Jones M, Steele C mBio. 2022; 13(5):e0225422.

PMID: 36040029 PMC: 9600342. DOI: 10.1128/mbio.02254-22.

References
1.
Cunha C, Di Ianni M, Bozza S, Giovannini G, Zagarella S, Zelante T . Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood. 2010; 116(24):5394-402. DOI: 10.1182/blood-2010-04-279307. View

2.
Willment J, Lin H, Reid D, Taylor P, Williams D, Wong S . Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol. 2003; 171(9):4569-73. DOI: 10.4049/jimmunol.171.9.4569. View

3.
Chai L, de Boer M, van der Velden W, Plantinga T, Spriel A, Jacobs C . The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis. J Infect Dis. 2011; 203(5):736-43. PMC: 3072717. DOI: 10.1093/infdis/jiq102. View

4.
Mehta R, Rezvani K . Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection. Virulence. 2016; 7(8):901-916. PMC: 5160395. DOI: 10.1080/21505594.2016.1208866. View

5.
Storek J, Geddes M, Khan F, Huard B, Helg C, Chalandon Y . Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol. 2008; 30(4):425-37. DOI: 10.1007/s00281-008-0132-5. View